Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500109293Phase 4Not yet recruiting
Phase 4, randomised trial in postoperative pain comparing bupivacaine + liposomal bupivacaine SAPB with Control: bupivacaine SAPB (2 arms). Primary endpoint: Mean NRS pain score at rest across 6 time points within 48 hours after surgery. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500109293.